204 related articles for article (PubMed ID: 9728000)
1. Antiviral drug resistance.
Pillay D; Zambon M
BMJ; 1998 Sep; 317(7159):660-2. PubMed ID: 9728000
[No Abstract] [Full Text] [Related]
2. [Viruses and antiviral drug resistance].
Hovi T; Järvinen A; Pyhälä R; Ristola M; Salminen M
Duodecim; 2002; 118(9):911-8. PubMed ID: 12238169
[No Abstract] [Full Text] [Related]
3. Summary of the III International Consensus Symposium on Combined Antiviral Therapy.
Cohen Stuart JW; Boucher CA; Cooper DA; Galasso GJ; Richman DD; Thomas HC; Whitley RJ
Antiviral Res; 1998 May; 38(2):75-93. PubMed ID: 9707371
[No Abstract] [Full Text] [Related]
4. [Etiotropic drug therapy of widespread and socially significant human viral infections].
Vasil'ev AN
Antibiot Khimioter; 2010; 55(3-4):29-34. PubMed ID: 20695206
[No Abstract] [Full Text] [Related]
5. [Etiotropic medicinal therapy of viral infections].
Galegov GA; Andronova VL; Leont'eva NA; L'vov ND; Petrova IG
Vopr Virusol; 2004; 49(3):35-40. PubMed ID: 15188653
[TBL] [Abstract][Full Text] [Related]
6. Antiviral therapies in children: has their time arrived?
Kimberlin DW
Pediatr Clin North Am; 2005 Jun; 52(3):837-67, vii. PubMed ID: 15925665
[TBL] [Abstract][Full Text] [Related]
7. Quo vadis antiviral agents for herpes, influenza and HIV?
Oxford JS
J Med Microbiol; 1995 Jul; 43(1):1-3. PubMed ID: 7608949
[No Abstract] [Full Text] [Related]
8. Part XIV. Antiviral agents other than antiretrovirals: therapy for herpesvirus infections, viral hepatitis, and influenza.
Lockhart SM; Salvaggio MR; Bronze MS; Greenfield RA
J Okla State Med Assoc; 2007 Oct; 100(10):388-95. PubMed ID: 18085096
[TBL] [Abstract][Full Text] [Related]
9. [Progress in chemotherapeutic agents--antiviral agents].
Morishima T
Nihon Rinsho; 1986 Apr; 44(4):852-7. PubMed ID: 3020270
[No Abstract] [Full Text] [Related]
10. [Antiviral therapy: from influenza to Pfeiffer's disease].
Salzberger B
Internist (Berl); 2006 Dec; 47(12):1245-50. PubMed ID: 17009040
[TBL] [Abstract][Full Text] [Related]
11. Recent advances in antiviral therapy.
Kinchington D
J Clin Pathol; 1999 Feb; 52(2):89-94. PubMed ID: 10396233
[TBL] [Abstract][Full Text] [Related]
12. [Herpesvirus hepatitis].
Suto T; Miyazawa J; Watanabe Y
Ryoikibetsu Shokogun Shirizu; 1995; (7):144-7. PubMed ID: 8749440
[No Abstract] [Full Text] [Related]
13. Is hepatitis virus resistance to antiviral drugs a threat?
Pawlotsky JM
Gastroenterology; 2012 May; 142(6):1369-72. PubMed ID: 22537445
[No Abstract] [Full Text] [Related]
14. Advances in antiviral therapy.
Dwyer DE; Kesson AM
Curr Opin Pediatr; 1997 Feb; 9(1):24-30. PubMed ID: 9088751
[TBL] [Abstract][Full Text] [Related]
15. [Characteristics of antiviral drugs].
Tuset M; Martín-Conde MT; Miró JM; Del Cacho E; Alberdi A; Codina C; Ribas J
Enferm Infecc Microbiol Clin; 2003 Oct; 21(8):433-57; quiz 458, 467. PubMed ID: 14525709
[TBL] [Abstract][Full Text] [Related]
16. Antiviral therapy: current options and challenges.
Reusser P
Schweiz Med Wochenschr; 2000 Jan; 130(4):101-12. PubMed ID: 10780051
[TBL] [Abstract][Full Text] [Related]
17. New antivirals - mechanism of action and resistance development.
Balzarini J; Naesens L; De Clercq E
Curr Opin Microbiol; 1998 Oct; 1(5):535-46. PubMed ID: 10066527
[TBL] [Abstract][Full Text] [Related]
18. Future antivirals-SMi conference: latest developments in HIV, hepatitis, herpes, influenza, RSV and SARS.
Harrison R
IDrugs; 2004 Jan; 7(1):34-6. PubMed ID: 14968814
[No Abstract] [Full Text] [Related]
19. Foscarnet therapy for AIDS-related opportunistic herpesvirus infections.
Jacobson MA
AIDS Clin Rev; 1992; ():173-89. PubMed ID: 1318736
[No Abstract] [Full Text] [Related]
20. [Mechanisms of antiviral resistance among the herpesvirus group].
Reina J
Enferm Infecc Microbiol Clin; 1997; 15(6):329-34. PubMed ID: 9376408
[No Abstract] [Full Text] [Related]
[Next] [New Search]
